Liu Yifei, Guthrie Kendall D, May Justin R, DiDonato Kristen L
Division of Pharmacy Practice and Administration, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA.
Bothwell Regional Health Center, Sedalia, MO 65301, USA.
Pharmacy (Basel). 2019 Jul 2;7(3):80. doi: 10.3390/pharmacy7030080.
To assess the clinical outcomes of participants of an employee wellness program during four years of service implementation. A prospective cohort study was conducted at 15 independent community pharmacy chain locations in northwest and central Missouri. A total of 200 participants were enrolled in an employee wellness program, and the program included five monitoring groups-cholesterol, blood pressure, blood glucose, weight, and healthy participant groups. Participants selected a pharmacist wellness coordinator and wellness appointments were conducted, consisting of education, goal-setting, and monitoring through physical assessment and point of care testing. The primary outcome measures were total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood glucose (FBG), body mass index (BMI), and waist circumference (WC). The secondary outcome measures were the proportion of patients who achieved the clinical value goals at baseline versus 48 months. The primary outcome measures among data collection time points were compared using one-way analysis of variance (ANOVA) tests, and the secondary outcomes were compared between baseline and 48 months by Chi-square or Fisher's exact tests. One-way ANOVA post hoc tests were also performed using least significant difference, to further identify which time points differed from each other. At baseline, there were 134 patients in the cholesterol monitoring group, 129 in the weight monitoring group, 117 in the blood pressure monitoring group, 46 in the blood glucose monitoring group, and 26 in the healthy participant monitoring group. For patients in the blood pressure monitoring group, compared with baseline, there was a significant decrease in DBP at months 12, 24, 36, and 48, and a significant increase in the proportion of patients achieving blood pressure goals at 48 months. For patients in the blood glucose monitoring group, compared with baseline, there was a significant decrease in FBG at months 12, 24, 36, and 48, and a significant increase in the proportion of patients achieving blood glucose goals at 48 months. Pharmacist-led wellness visits provided to employee wellness patients in a community pharmacy may lead to improvements in BP and FBG values.
评估一项员工健康计划在实施四年期间参与者的临床结局。在密苏里州西北部和中部的15个独立社区药房连锁店开展了一项前瞻性队列研究。共有200名参与者加入了一项员工健康计划，该计划包括五个监测组——胆固醇、血压、血糖、体重和健康参与者组。参与者选择了一名药剂师健康协调员，并进行了健康预约，包括教育、目标设定以及通过体格检查和即时检验进行监测。主要结局指标包括总胆固醇（TC）、甘油三酯（TG）、高密度脂蛋白胆固醇（HDL-C）、低密度脂蛋白胆固醇（LDL-C）、收缩压（SBP）、舒张压（DBP）、空腹血糖（FBG）、体重指数（BMI）和腰围（WC）。次要结局指标是在基线时与48个月时达到临床价值目标的患者比例。使用单因素方差分析（ANOVA）检验比较数据收集时间点之间的主要结局指标，并通过卡方检验或费舍尔精确检验比较基线和48个月时的次要结局。还使用最小显著差异进行单因素方差分析事后检验，以进一步确定哪些时间点彼此不同。在基线时，胆固醇监测组有134名患者，体重监测组有129名患者，血压监测组有117名患者，血糖监测组有46名患者，健康参与者监测组有26名患者。对于血压监测组中的患者，与基线相比，在第12个月、24个月、36个月和48个月时DBP显著降低，在48个月时达到血压目标的患者比例显著增加。对于血糖监测组中的患者，与基线相比，在第12个月、24个月、36个月和48个月时FBG显著降低，在48个月时达到血糖目标的患者比例显著增加。在社区药房为员工健康患者提供的由药剂师主导的健康访视可能会改善血压和空腹血糖值。
